NewLink Genetics Corporation

(NLNK) Trade

By |

Profile

NewLink Genetics Corp is a clinical stage immuno-oncology company based in US. It focuses on developing novel immunotherapeutic products for the treatment of cancer. Its portfolio contains biologic and small-molecule immuno-oncology product candidates.

Contact Information

Website: www.newlinkgenetics.com
Email: info@newlinkgenetics.com
Main Phone: +1 515 296-5555
Address: 2503 South Loop Drive
Address 2: Suite 5100
State: IA
City / Town: Ames
Country: USA
Postal Code: 50010

Issuer Information

Exchange: NSD
CEO: Charles J. Link
Employees: 76
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 2.48 $ 0.10 (4.20%)
Last Price 2.48 Change $ 0.10 Change % 4.20 Tick N/A
Bid 2.48 Bid Size 800.00 Ask 2.49 Ask Size 1,100.00
Open 2.39 High 2.55 Low 2.39 Prev Close 2.38
Last Trade Volume 221,619 52 Wk Hi 12.91 52 Wk Low 2.31
Market Cap 92.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 37,214,286.00 EPS (TTM) -1.97 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 15
Number of Buys 0 1
Number of Sells 0 14
Net Activity 0 -21461
Last 10 Buys Shares
Ernest J. Talarico 1,000
John B. Henneman 1,000
John B. Henneman 1,000
Charles J. Link 1,000
David J. Lundquist 1,000
Last 10 Sell Shares
Carl W. Langren 1,000
Carl W. Langren 1,000
Charles J. Link 1,000
Charles J. Link 1,000
Charles J. Link 1,000
Charles J. Link 1,000
Charles J. Link 1,000
Charles J. Link 1,000
Charles J. Link 1,000
Brian Wiley 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 8 8 8 8
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 5.83 5.83 5.83 5.83
Standard Deviation 1.47 1.47 1.47 1.47
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 2 6
Moderate Buy 0 0 0 0
Hold 5 5 4 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.67 2.67 2.33 1